Quantitative metabolic parameters measured on F-18 FDG PET/CT predict survival after relapse in patients with relapsed epithelial ovarian cancer

Clinical usefulness of post-treatment FDG PET/CT in patients with ovarian malignancy

“…2). In agreement with these results, previous studies reported that post-treatment PET/CT result was a significant prognostic factor of survival in patients with ovarian cancer [25,26,28,29].…”

Could semiquantitative FDG analysis add information to the prognosis in patients with stage II/III breast cancer undergoing neoadjuvant treatment?

“…The authors found that WB TLG was a significant predictor of OS in [16][17][18][19][20][21][22]. As stated by Chen et al [23], FDG PET is a WB examination, and therefore can provide full information on the glucose metabolism of lesions.…”

Predictive value of 18F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study

“…The value of semiquantitative measurements in restaging of ovarian cancer is contentious. Some studies [17,18] suggested a value to SUV calculations in the prognostic assessment. Conversely, other studies [19] reported no predictive value for SUV max .…”

“…4 years). As such, the inherent limitations of the previous studies [17,19] have been at least partly overcome.…”